Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jun 20 2024

Full Issue

Viewpoints: How Likely Is It You'll To Be Exposed To Bird Flu?; Ozempic Can Do Much More Than Weight Loss

Editorial writers discuss H5N1, weight-loss drugs, pharmaceutical advertising, and more.

The New York Times: How Scared Should You Be Of Bird Flu? 

How worried you should be about H5N1, the bird flu virus spreading on dairy farms in the United States, depends on who you are. (Jennifer B. Nuzzo, 6/19)

Bloomberg: Ozempic's Addiction-Fighting Potential Is Being Ignored

The anecdotes are increasingly impossible to ignore: Many people taking the new obesity drugs, whether Novo Nordisk’s Wegovy or Eli Lilly & Co.’s Zepbound, aren’t just eating less, they’re drinking and smoking less, too. (Lisa Jarvis, 6/20)

The New York Times: It’s Time To Ban Pharmaceutical Advertising 

“Zofran girlies rise up.” Seeing that phrase on my screen as I idly scrolled TikTok made me stop and watch the whole video, but probably not for the reasons its creator wanted. (Jessica Grose, 6/19)

Scientific American: The World Desperately Needs A New Pandemic Treaty 

Here’s why a pandemic treaty would be a win for people everywhere, in the Global North and South. Think of a pandemic treaty as a grand social bargain to protect future generations from the devastating and inequitable impacts of pandemics. (Lawrence O. Gostin and Alexandra Finch, 6/19)

Stat: Getting Ahead Of A Non-Alcoholic Beverage Boom Among Youths

While it’s great that more people are taking to heart public health messages that reducing alcohol consumption can improve well-being and extend life, an important lesson from vaping as a replacement for cigarettes is being overlooked: What may be good for adults may be harmful to kids. Without any meaningful restrictions on the sale of non-alcoholic beverages to youths, the country is just one JUUL-like marketing push away from a potential public health crisis. (Molly Bowdring, Aaron S.B. Weiner and Judith Prochaska, 6/20)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 29
  • Thursday, May 28
  • Wednesday, May 27
  • Tuesday, May 26
  • Friday, May 22
  • Thursday, May 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF